GridAI Technologies (GRDX) Exchange Rate Effect (2015 - 2022)
GridAI Technologies' (GRDX) quarterly Exchange Rate Effect came in at -$226045.0 in Q4 2022, down 397.39% YoY from $76010.0 in Q4 2021, and down 3965.34% on a QoQ basis from $5848.0 in Q3 2022.
GridAI Technologies (GRDX) Exchange Rate Effect (2015 - 2022) Analysis & Trends
GridAI Technologies (GRDX) has 8 years of Exchange Rate Effect data on file, last reported at -$226045.0 in Q4 2022.
- Quarterly Exchange Rate Effect fell 397.39% year-over-year to -$226045.0 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was -$259713.0 (down 944.43% YoY) and the FY2025 annual result came in at $204751.0, changed N/A from the prior year.
- Exchange Rate Effect eased to -$226045.0 in Q4 2022, from $5848.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $76010.0 in Q4 2021 to a low of -$226045.0 in Q4 2022.
- A 5-year average of -$13846.7 and a median of -$6166.5 in 2018 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2019 — Exchange Rate Effect sank 2809.67% — and 2020, when it jumped 468.92%.
- Tracing GRDX's Exchange Rate Effect over 5 years: stood at $29469.0 in 2018, then plunged by 57.9% to $12406.0 in 2019, then sank by 576.47% to -$59111.0 in 2020, then soared by 228.59% to $76010.0 in 2021, then plunged by 397.39% to -$226045.0 in 2022.
- The last three Exchange Rate Effect figures came in at -$226045.0 (Q4 2022), $5848.0 (Q3 2022), and -$30747.0 (Q2 2022), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.66 Bn | 131.80 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 86.52 Bn | 78.53 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 65.33 Bn | 60.14 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.76 Bn | 54.62 Bn | 52.00 Mn | -2.00 Mn |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn | 19.84 Mn |
| 6 | Alnylam Pharmaceuticals | 31.84 Bn | 28.53 Bn | 992.69 Mn | -2.45 Mn |
| 7 | BioNTech SE | 28.23 Bn | 9.84 Bn | 668.28 Mn | 1.63 Mn |
| 8 | Insmed | 27.52 Bn | 26.36 Bn | 358.27 Mn | -287,000.00 |
| 9 | Royalty Pharma | 27.29 Bn | 26.46 Bn | - | - |
| 10 | GridAI Technologies | 5.95 Mn | 5.95 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | -226,045.00 |
| Dec 31, 2022 | -226,045.00 |
| Sep 30, 2022 | 5,848.00 |
| Sep 30, 2022 | 5,848.00 |
| Jun 30, 2022 | -30,747.00 |
| Jun 30, 2022 | -30,747.00 |
| Mar 31, 2022 | -8,769.00 |
| Mar 31, 2022 | -8,769.00 |
| Dec 31, 2021 | 76,010.00 |
| Dec 31, 2021 | 76,010.00 |
| Sep 30, 2021 | 4,940.00 |
| Sep 30, 2021 | 4,940.00 |
| Jun 30, 2021 | -36,456.00 |
| Jun 30, 2021 | -36,456.00 |
| Mar 31, 2021 | -13,738.00 |
| Mar 31, 2021 | -13,738.00 |
| Dec 31, 2020 | -59,111.00 |
| Dec 31, 2020 | -59,111.00 |
| Sep 30, 2020 | 20,423.00 |
| Sep 30, 2020 | 20,423.00 |